Bristol-Myers Squibb Foundation Awards GRU Cancer Center Three-Year, $1.74M Grant To Address Lung Cancer Among Neediest Communities In Central Savannah River Area
NEW YORK--(BUSINESS WIRE)--The Bristol-Myers Squibb Foundation today announced a three-year, $1.74 million grant to the GRU Cancer Center for a pilot program to reduce the burden of lung cancer among underserved populations in Georgia’s Central Savannah River Area (CSRA) by focusing on prevention, early detection, education and helping people with suspected or diagnosed lung cancer access and navigate cancer care and community-based supportive services in the region. The project’s interventions will be tested for potential use statewide.
The grant, which was made through the Foundation’s Bridging Cancer Care™ initiative, will help the GRU Cancer Center launch the lung cancer module of its cancer-Community Awareness Access Research and Education initiative, or c-CARE, which seeks to more broadly address all cancers that are preventable or may be detected early enough to improve outcomes.
Help employers find you! Check out all the jobs and post your resume.
The grant, which was made through the Foundation’s Bridging Cancer Care™ initiative, will help the GRU Cancer Center launch the lung cancer module of its cancer-Community Awareness Access Research and Education initiative, or c-CARE, which seeks to more broadly address all cancers that are preventable or may be detected early enough to improve outcomes.
Help employers find you! Check out all the jobs and post your resume.